Dr. Maurice Leibman, MD

NPI: 1023017001
Total Payments
$34,561
2024 Payments
$3,000
Companies
45
Transactions
626
Medicare Patients
900
Medicare Billing
$68,379

Payment Breakdown by Category

Other$20,200 (58.4%)
Food & Beverage$9,354 (27.1%)
Travel$2,829 (8.2%)
Consulting$1,500 (4.3%)
Education$549.13 (1.6%)
Gifts$128.49 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,700 12 54.1%
Food and Beverage $9,354 414 27.1%
Travel and Lodging $2,829 15 8.2%
Honoraria $1,500 1 4.3%
Consulting Fee $1,500 1 4.3%
Education $549.13 43 1.6%
Gift $128.49 140 0.4%

Top Paying Companies

Company Total Records Latest Year
AMAG Pharmaceuticals, Inc. $22,459 81 $0 (2020)
ASCEND THERAPEUTICS US, LLC $3,490 177 $0 (2024)
Novo Nordisk Inc $1,186 32 $0 (2023)
Acessa Health Inc. $1,088 5 $0 (2022)
Vertical Pharmaceuticals, LLC $917.94 87 $0 (2020)
ABBVIE INC. $831.69 29 $0 (2022)
Amgen Inc. $804.55 23 $0 (2023)
TherapeuticsMD, Inc. $612.02 29 $0 (2022)
PFIZER INC. $358.66 22 $0 (2023)
MAYNE PHARMA INC. $279.56 11 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,000 2 ASCEND THERAPEUTICS US, LLC ($3,000)
2023 $567.89 23 Amgen Inc. ($127.93)
2022 $1,499 51 MAYNE PHARMA INC. ($228.69)
2021 $1,144 129 AbbVie Inc. ($245.02)
2020 $829.59 38 AbbVie Inc. ($225.93)
2019 $2,530 138 Acessa Health Inc. ($968.60)
2018 $19,491 109 AMAG Pharmaceuticals, Inc. ($18,291)
2017 $5,499 136 AMAG Pharmaceuticals, Inc. ($3,948)

All Payment Transactions

626 individual payment records from CMS Open Payments — Page 1 of 26

Date Company Product Nature Form Amount Type
03/27/2024 ASCEND THERAPEUTICS US, LLC ESTROGEL (Drug) Honoraria Cash or cash equivalent $1,500.00 General
Category: Women's Health
03/27/2024 ASCEND THERAPEUTICS US, LLC ESTROGEL (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Women's Health
08/02/2023 ASCEND THERAPEUTICS US, LLC ESTROGEL (Drug) Food and Beverage In-kind items and services $22.94 General
Category: Women's Health
07/27/2023 Kowa Pharmaceuticals America, Inc. SEGLENTIS (Drug) Food and Beverage In-kind items and services $25.07 General
Category: PAIN MANAGEMENT
06/29/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $25.30 General
Category: Biological
06/21/2023 ASCEND THERAPEUTICS US, LLC ESTROGEL (Drug) Food and Beverage In-kind items and services $22.83 General
Category: Women's Health
06/08/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $29.59 General
Category: HORMONE THERAPY
05/17/2023 Exeltis, USA Inc. Solosec (Drug) Food and Beverage In-kind items and services $14.25 General
Category: Bacterial Vaginosis
05/10/2023 Exeltis, USA Inc. Solosec (Drug) Food and Beverage In-kind items and services $17.65 General
Category: Bacterial Vaginosis
05/04/2023 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $17.74 General
Category: Obesity
04/25/2023 Currax Pharmaceuticals LLC CONTRAVE (Drug) Food and Beverage In-kind items and services $12.81 General
Category: Obesity
03/28/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $24.90 General
Category: HORMONE THERAPY
03/23/2023 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $25.98 General
03/16/2023 Currax Pharmaceuticals LLC CONTRAVE (Drug) Food and Beverage In-kind items and services $14.73 General
Category: Obesity
03/15/2023 Gynesonics, Inc. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) Food and Beverage In-kind items and services $15.47 General
Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM
03/15/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $13.20 General
Category: INSOMNIA
03/08/2023 PFIZER INC. PREMARIN (Drug), MYFEMBREE, NURTEC ODT Food and Beverage In-kind items and services $16.60 General
Category: WOMENS HEALTH
03/07/2023 Kowa Pharmaceuticals America, Inc. SEGLENTIS (Drug) Food and Beverage In-kind items and services $21.08 General
Category: PAIN MANAGEMENT
03/01/2023 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $24.99 General
Category: Obesity
03/01/2023 Exeltis, USA Inc. Solosec (Drug) Food and Beverage In-kind items and services $14.80 General
Category: Bacterial Vaginosis
02/23/2023 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $110.43 General
Category: Bone Health
01/31/2023 Bayer Healthcare Pharmaceuticals Inc. Kyleena (Drug) Food and Beverage In-kind items and services $30.08 General
Category: Womens Health
01/25/2023 ASCEND THERAPEUTICS US, LLC ESTROGEL (Drug) Food and Beverage In-kind items and services $22.16 General
Category: Women's Health
01/24/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $27.79 General
Category: HORMONE THERAPY
01/04/2023 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $17.50 General
Category: Bone Health

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 125 140 $24,945 $7,055
2022 7 273 319 $69,319 $21,893
2021 8 280 315 $54,716 $23,197
2020 6 222 263 $33,434 $16,235
Total Patients
900
Total Services
1,037
Medicare Billing
$68,379
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 51 65 $10,850 $3,574 32.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 20 20 $6,032 $1,482 24.6%
76830 Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina Office 2023 11 12 $5,008 $927.25 18.5%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2023 14 14 $1,194 $558.74 46.8%
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous Office 2023 29 29 $1,862 $513.01 27.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 64 83 $25,129 $7,102 28.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 84 106 $17,694 $6,504 36.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 17 17 $6,226 $2,312 37.1%
76830 Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina Office 2022 21 26 $10,850 $2,286 21.1%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2022 49 49 $4,331 $1,999 46.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 12 12 $3,421 $1,226 35.8%
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous Office 2022 26 26 $1,669 $464.98 27.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 50 73 $17,155 $7,118 41.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 85 92 $11,165 $5,295 47.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 32 32 $9,766 $4,388 44.9%
76830 Ultrasound pelvis through vagina Office 2021 18 23 $7,552 $2,206 29.2%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2021 49 49 $4,177 $1,995 47.8%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 12 12 $3,082 $1,611 52.3%
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous Office 2021 20 20 $1,070 $361.00 33.7%
82274 Stool analysis for blood, by fecal hemoglobin determination by immunoassay Office 2021 14 14 $749.00 $222.88 29.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 82 109 $8,968 $5,262 58.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 37 48 $7,501 $3,630 48.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 28 28 $8,545 $3,335 39.0%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 16 16 $4,109 $1,859 45.2%
76830 Ultrasound pelvis through vagina Office 2020 11 14 $1,744 $1,287 73.8%

About Dr. Maurice Leibman, MD

Dr. Maurice Leibman, MD is a Obstetrics & Gynecology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023017001.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maurice Leibman, MD has received a total of $34,561 in payments from pharmaceutical and medical device companies, with $3,000 received in 2024. These payments were reported across 626 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,700).

As a Medicare-enrolled provider, Leibman has provided services to 900 Medicare beneficiaries, totaling 1,037 services with total Medicare billing of $68,379. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Other Specialties Gynecology
  • Location Houston, TX
  • Active Since 07/20/2005
  • Last Updated 02/23/2011
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1023017001

Products in Payments

  • INTRAROSA (Drug) $22,477
  • ESTROGEL (Drug) $3,369
  • Acessa (Drug) $968.60
  • Saxenda (Drug) $939.14
  • DIVIGEL (Drug) $896.08
  • IMVEXXY (Drug) $354.25
  • Prolia (Biological) $295.54
  • EVENITY (Biological) $293.01
  • ORILISSA (Drug) $288.13
  • PREMARIN (Drug) $281.08
  • MYFEMBREE (Drug) $274.85
  • ANNOVERA (Drug) $257.77
  • LO LOESTRIN FE (Drug) $226.28
  • CONTRAVE (Drug) $214.41
  • Wegovy (Drug) $197.80
  • Lupron (Drug) $184.43
  • MYRBETRIQ (Drug) $178.97
  • ARISTA AH FLEXITIP (Device) $162.15
  • ORIAHNN (Drug) $150.60
  • Kyleena (Drug) $142.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Houston